Pitching session

BioPitch: Igniting Innovation at Swiss Biotech Day with Nucleate

Date:April 22, 2024

Pitch summary

Discover groundbreaking innovations from Switzerland’s early-stage life science startups at Nucleate’s pitching session. These startups, part of Nucleate’s Activator program, are revolutionizing human health challenges. Run by academic trainees, Nucleate fosters technology commercialization, offering equity-free support and connecting budding entrepreneurs with a prestigious advisor network.

Pitching companies

  • SYDRA (Title: AI-assisted + in vivo discovery of novel geroprotectors)
  • IMPLANZ (Title: Surgical excellence for dental implantology)
  • inSEIT (Title: Immobilize to go further in industrial biocatalysis)
  • Inkocell (Title: Curing cardiac fibrosis)
  • EVIIVE (Title: Next-Gen Liquid Biopsy Biomarker Discovery Solution: Intercepting Cellular Communication for Precision Medicine)
  • DropGen (Title: Miniaturized high-throughput screening of antimicrobial resistance (AMR))

Jury members

  • Katharina Kreymborg, SVP, CSO Partner Team, Curie.Bio
  • Zoë Johnson, CSO & CDO, M:M Bio
  • Antoine Boulanger, Principal, Forbion


  • Rishika Agarwal, Co Managing Director, Nucleate Switzerland
  • Sara Svanberg, Co Managing Director, Nucleate Switzerland